Cargando…
Gamma-secretase activating protein, a therapeutic target for Alzheimer's disease
Accumulation of neurotoxic βamyloid (Aβ) is a major hallmark of Alzheimer's disease (AD)1. Formation of Aβ is catalyzed by γsecretase, a protease with numerous substrates2,3. Little is known about the molecular mechanisms that confer substrate specificity on this potentially promiscuous enzyme....
Autores principales: | He, Gen, Luo, Wenjie, Li, Peng, Remmers, Christine, Netzer, William, Hendrick, Joseph, Bettayeb, Karima, Flajolet, Marc, Gorelick, Fred, Wennogle, Lawrence P., Greengard, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936959/ https://www.ncbi.nlm.nih.gov/pubmed/20811458 http://dx.doi.org/10.1038/nature09325 |
Ejemplares similares
-
GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer’s disease
por: Xu, Peng, et al.
Publicado: (2021) -
Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
por: Tate, Barbara, et al.
Publicado: (2012) -
Gamma-secretase: from pathogenesis to therapeutics
por: Li, Yueming
Publicado: (2012) -
Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
por: Netzer, William J., et al.
Publicado: (2010) -
Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
por: Nordvall, Gunnar, et al.
Publicado: (2023)